A recombinant Der p 1-specific allergen-toxin demonstrates superior killing of allergen-reactive IgG+ hybridomas in comparison to its recombinant allergen-drug conjugate.
Saved in:
| Title: | A recombinant Der p 1-specific allergen-toxin demonstrates superior killing of allergen-reactive IgG+ hybridomas in comparison to its recombinant allergen-drug conjugate. |
|---|---|
| Authors: | Daramola AK; South African Research Chair in Cancer Biotechnology, Department of Integrative Biomedical Sciences, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Medical Biotechnology & Immunotherapy Research Unit, Institute of Infectious Disease and Molecular Medicine (IDM), Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Akinrinmade OA; South African Research Chair in Cancer Biotechnology, Department of Integrative Biomedical Sciences, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Medical Biotechnology & Immunotherapy Research Unit, Institute of Infectious Disease and Molecular Medicine (IDM), Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461, USA., Fajemisin EA; South African Research Chair in Cancer Biotechnology, Department of Integrative Biomedical Sciences, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Medical Biotechnology & Immunotherapy Research Unit, Institute of Infectious Disease and Molecular Medicine (IDM), Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Naran K; South African Research Chair in Cancer Biotechnology, Department of Integrative Biomedical Sciences, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Medical Biotechnology & Immunotherapy Research Unit, Institute of Infectious Disease and Molecular Medicine (IDM), Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Mthembu N; Division of Immunology, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Hadebe S; Division of Immunology, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Brombacher F; Division of Immunology, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; International Centre for Genetic Engineering and Biotechnology (ICGEB) and Institute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology, Faculty of Health Sciences, University of Cape Town, South Africa.; Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Diseases and Molecular Medicine (IDM), Faculty of Health Sciences, University of Cape Town, South Africa., Huysamen AM; Department of Chemistry, Faculty of Sciences, University of Cape Town, Cape Town, South Africa., Fadeyi OE; Department of Chemistry, Faculty of Sciences, University of Cape Town, Cape Town, South Africa., Hunter R; Department of Chemistry, Faculty of Sciences, University of Cape Town, Cape Town, South Africa., Barth S; South African Research Chair in Cancer Biotechnology, Department of Integrative Biomedical Sciences, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Medical Biotechnology & Immunotherapy Research Unit, Institute of Infectious Disease and Molecular Medicine (IDM), Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. |
| Source: | Immunotherapy advances [Immunother Adv] 2022 Dec 06; Vol. 3 (1), pp. ltac023. Date of Electronic Publication: 2022 Dec 06 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101776979 Publication Model: eCollection Cited Medium: Internet ISSN: 2732-4303 (Electronic) Linking ISSN: 27324303 NLM ISO Abbreviation: Immunother Adv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36789295 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A recombinant Der p 1-specific allergen-toxin demonstrates superior killing of allergen-reactive IgG<superscript>+</superscript> hybridomas in comparison to its recombinant allergen-drug conjugate. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Daramola+AK%22">Daramola AK</searchLink>; South African Research Chair in Cancer Biotechnology, Department of Integrative Biomedical Sciences, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Medical Biotechnology & Immunotherapy Research Unit, Institute of Infectious Disease and Molecular Medicine (IDM), Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Akinrinmade+OA%22">Akinrinmade OA</searchLink>; South African Research Chair in Cancer Biotechnology, Department of Integrative Biomedical Sciences, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Medical Biotechnology & Immunotherapy Research Unit, Institute of Infectious Disease and Molecular Medicine (IDM), Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.<br /><searchLink fieldCode="AU" term="%22Fajemisin+EA%22">Fajemisin EA</searchLink>; South African Research Chair in Cancer Biotechnology, Department of Integrative Biomedical Sciences, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Medical Biotechnology & Immunotherapy Research Unit, Institute of Infectious Disease and Molecular Medicine (IDM), Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Naran+K%22">Naran K</searchLink>; South African Research Chair in Cancer Biotechnology, Department of Integrative Biomedical Sciences, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Medical Biotechnology & Immunotherapy Research Unit, Institute of Infectious Disease and Molecular Medicine (IDM), Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Mthembu+N%22">Mthembu N</searchLink>; Division of Immunology, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Hadebe+S%22">Hadebe S</searchLink>; Division of Immunology, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Brombacher+F%22">Brombacher F</searchLink>; Division of Immunology, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; International Centre for Genetic Engineering and Biotechnology (ICGEB) and Institute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology, Faculty of Health Sciences, University of Cape Town, South Africa.; Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Diseases and Molecular Medicine (IDM), Faculty of Health Sciences, University of Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Huysamen+AM%22">Huysamen AM</searchLink>; Department of Chemistry, Faculty of Sciences, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Fadeyi+OE%22">Fadeyi OE</searchLink>; Department of Chemistry, Faculty of Sciences, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Hunter+R%22">Hunter R</searchLink>; Department of Chemistry, Faculty of Sciences, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Barth+S%22">Barth S</searchLink>; South African Research Chair in Cancer Biotechnology, Department of Integrative Biomedical Sciences, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Medical Biotechnology & Immunotherapy Research Unit, Institute of Infectious Disease and Molecular Medicine (IDM), Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101776979%22">Immunotherapy advances</searchLink> [Immunother Adv] 2022 Dec 06; Vol. 3 (1), pp. ltac023. <i>Date of Electronic Publication: </i>2022 Dec 06 (<i>Print Publication: </i>2023). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101776979 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2732-4303 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2227324303%22">27324303 </searchLink><i>NLM ISO Abbreviation: </i>Immunother Adv <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36789295 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/immadv/ltac023 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: ltac023 Titles: – TitleFull: A recombinant Der p 1-specific allergen-toxin demonstrates superior killing of allergen-reactive IgG+ hybridomas in comparison to its recombinant allergen-drug conjugate. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Daramola AK – PersonEntity: Name: NameFull: Akinrinmade OA – PersonEntity: Name: NameFull: Fajemisin EA – PersonEntity: Name: NameFull: Naran K – PersonEntity: Name: NameFull: Mthembu N – PersonEntity: Name: NameFull: Hadebe S – PersonEntity: Name: NameFull: Brombacher F – PersonEntity: Name: NameFull: Huysamen AM – PersonEntity: Name: NameFull: Fadeyi OE – PersonEntity: Name: NameFull: Hunter R – PersonEntity: Name: NameFull: Barth S IsPartOfRelationships: – BibEntity: Dates: – D: 06 M: 12 Text: 2022 Dec 06 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 2732-4303 Numbering: – Type: volume Value: 3 – Type: issue Value: 1 Titles: – TitleFull: Immunotherapy advances Type: main |
| ResultId | 1 |
